
Inside Novo Nordisk’s $33B manufacturing push to strengthen its obesity portfolio and build a biologics powerhouse
We mined Novo Nordisk’s acquisitions, investments, and partnerships to discern its strategic priorities and future plans.
Article Metadata
Apr 25, 2025